Addressing Barriers for Women with Advanced Heart Failure

Oliveros, Estefania; Saldarriaga Giraldo, Clara Inés; Hall, Jillian; Tinuoye, Elizabeth; Rodriguez, Maria Juliana; Gallego, Catalina; Contreras, Johanna Paola

doi:10.1007/s11886-023-01946-y

Cited by 4 publications

(14 citation statements)

References 79 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, when they are referred, they are younger with fewer comorbidities compared to men, and their survival does not differ from men. 61,62 Additional challenges for women include lack of insurance, absence of caregivers, poor health literacy, and depression. 62 Overcoming sex and gender disparities in heart failure care is critical to provide equitable treatment to the millions of women affected by this condition.…”

Section: Device Therapymentioning

confidence: 99%

Sex Disparities in Cardiovascular Disease

Mahowald,

Esmail,

Ezzeddine

et al. 2024

Methodist DeBakey Cardiovascular Journal

View full text Add to dashboard Cite

Cardiovascular disease is the leading cause of death in women. It remains underdiagnosed, undertreated, and portends worse outcomes in women than men. Disparities exist in every stage of science, from bench research to the editorial board of major journals and in every cardiovascular subspecialty. This review summarizes differences in cardiovascular risk factors and disparities in management and outcomes of ischemic heart disease, heart failure, aortic stenosis, and atrial fibrillation. It also provides an overview of female representation as participants and leaders of clinical trials, editorial boards, and academic institutions. Strategies to overcome these disparities are proposed with examples of successful programs.

show abstract

Section: Device Therapymentioning

confidence: 99%

Sex Disparities in Cardiovascular Disease

Mahowald,

Esmail,

Ezzeddine

et al. 2024

Methodist DeBakey Cardiovascular Journal

View full text Add to dashboard Cite

show abstract

“…1,2,5 Women's Hearts differ considerably compared to men's hearts. 1,7,14 These differences are structural and physiological. They have lower left ventricle mass, greater contractility, different apoptosis rates, smaller coronary vessels, higher resting heart rates, different responses to catecholamine, smaller vascular beds, and small bodies.…”

Section: Coronary Heart Disease and Cardiovascular Intervention In La...mentioning

confidence: 99%

“…They have lower left ventricle mass, greater contractility, different apoptosis rates, smaller coronary vessels, higher resting heart rates, different responses to catecholamine, smaller vascular beds, and small bodies. 7,13,14 Hormonal differences are presumed to alter the endothelial response to injury and different responses to the renin-angiotensin-aldosterone system. In consequence, some measures change; LVEF is higher in women than men with higher stroke volume for a given end-diastolic volume in smaller cavities.…”

Section: Coronary Heart Disease and Cardiovascular Intervention In La...mentioning

confidence: 99%

“…1,13 Biomarkers also have differences, including, for example, that the levels of the natriuretic peptides are higher in women than men. 7,14 Clinical presentations in CHF, talking about the syndrome (signs and symptoms), are mostly the same. However, women present different phenotypes in HF; reduced, mildly reduced, and preserved with a predominance of preserved phenotype (HFpEF) 1,7,14 .…”

Section: Coronary Heart Disease and Cardiovascular Intervention In La...mentioning

confidence: 99%

“…7,14 Clinical presentations in CHF, talking about the syndrome (signs and symptoms), are mostly the same. However, women present different phenotypes in HF; reduced, mildly reduced, and preserved with a predominance of preserved phenotype (HFpEF) 1,7,14 . The situation with women is that they do not look for attention as men do; they are the caregivers.…”

Section: Coronary Heart Disease and Cardiovascular Intervention In La...mentioning

confidence: 99%

See 2 more Smart Citations

Cardiovascular Disease in Latin American Women Gaps and opportunities

Dueñas-Criado,

Peña,

Rodriguez-González

et al. 2024

International Journal of Cardiovascular Sciences

View full text Add to dashboard Cite

Cardiovascular disease (CVD) remains the leading cause of death in women. This review will address the known disparities in cardiovascular care concerning diagnosing and treating of heart disease in Latin American (LA) women. Gender-specific differences regarding the incidence, treatment, and outcomes of common cardiovascular pathology are increasingly recognized. Today, we identify that women have cardiovascular risk factors (CRFs), specifying the traditional, emerging, unique, or sex-specific determinants and the social and biological determinants that play a leading role in the prevention of CVD. The purpose of this article is to review the literature on cardiovascular disease in LA women, focusing on ischemic heart disease (IHD), valve disease (VD), heart failure, and cardiac rehabilitation (CR), where disparities continue to affect outcomes. Understanding the unique cardiovascular risk profile and barriers to optimal treatment outcomes in women is imperative to eliminate the current disparities in CVD. EpidemiologyCardiovascular diseases (CVD) continue to be the leading cause of death in women, representing approximately 35% of all female deaths worldwide,

show abstract